<scp>ACAGT</scp>‐007a, an anti‐cancer compound that modulates <scp>ERK MAPK</scp> signaling, induces nuclear enrichment of phosphorylated <scp>ERK</scp> in <scp>T3M4</scp> pancreatic cancer cells
Golam Iftakhar Khandakar(Kindai University), Reiko Sugiura(Kindai University)
Cited by 0
Related Papers
Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target
|Oncotarget|2021|17
Down‐regulation of dual‐specificity phosphatase 6, a negative regulator of oncogenic ERK signaling, by ACA‐28 induces apoptosis in NIH/3T3 cells overexpressing HER2/ErbB2
|Genes to Cells|2020|9
Rapamycin Abrogates Aggregation of Human α‐Synuclein Expressed in Fission Yeast via an Autophagy‐Independent Mechanism
|Genes to Cells|2024|5
ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells
|Oxidative Medicine and Cellular Longevity|2024|3